These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6092715)

  • 1. Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.
    Kasel JA; Frank AL; Keitel WA; Taber LH; Glezen WP
    J Virol; 1984 Dec; 52(3):828-32. PubMed ID: 6092715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses.
    Ray R; Compans RW
    Virology; 1986 Jan; 148(1):232-6. PubMed ID: 2417412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters.
    Rydbeck R; Löve A; Norrby E
    J Gen Virol; 1988 May; 69 ( Pt 5)():1019-24. PubMed ID: 2836547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.
    Ray R; Glaze BJ; Compans RW
    J Virol; 1988 Mar; 62(3):783-7. PubMed ID: 2828674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies.
    Rydbeck R; Löve A; Orvell C
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine.
    Ray R; Brown VE; Compans RW
    J Infect Dis; 1985 Dec; 152(6):1219-30. PubMed ID: 2999259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles.
    Ray R; Compans RW
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():409-18. PubMed ID: 3029283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.
    Spriggs MK; Murphy BR; Prince GA; Olmsted RA; Collins PL
    J Virol; 1987 Nov; 61(11):3416-23. PubMed ID: 2822951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in bovine parainfluenza 3 virus variants studied by monoclonal antibodies against viral glycoproteins.
    Shibuta H; Suzu S; Shioda T
    Virology; 1986 Dec; 155(2):688-96. PubMed ID: 3024407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens.
    Julkunen I
    J Med Virol; 1984; 14(2):177-87. PubMed ID: 6092530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies.
    Rydbeck R; Orvell C; Löve A; Norrby E
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1531-42. PubMed ID: 2426392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies.
    Tsurudome M; Nishio M; Komada H; Bando H; Ito Y
    Virology; 1989 Jul; 171(1):38-48. PubMed ID: 2545038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine parainfluenza-3 virus proteins recognized by antibodies of aerosol-exposed calves.
    Toth TE; Frank GH
    Am J Vet Res; 1988 Nov; 49(11):1945-9. PubMed ID: 2854712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meaning of circulating antibody titers in the infections of parainfluenza 3 virus and RS virus.
    Fukumi H
    Dev Biol Stand; 1975; 28():159-66. PubMed ID: 165115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins.
    Heminway BR; Yu Y; Galinski MS
    Virus Res; 1994 Jan; 31(1):1-16. PubMed ID: 8165862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody appearance of parainfluenza-3 virus in cattle population in West Azerbaijan Province.
    Mozaffari-Nezhad H; Kita J
    Pol Arch Weter; 1980; 21(4):473-6. PubMed ID: 6259631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion.
    Ebata SN; Côté MJ; Kang CY; Dimock K
    Virology; 1991 Jul; 183(1):437-41. PubMed ID: 1647076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.